Skip to main content
. Author manuscript; available in PMC: 2020 Aug 27.
Published in final edited form as: Genet Med. 2020 Feb 27;22(6):1102–1107. doi: 10.1038/s41436-020-0767-8

Figure 1.

Figure 1

a Total score in Nijmegen pediatric CDG rating scale (before and after galactose supplementation)

Mean total NPCRS score improved from 28.7 ± 9.7 to 24.6 ± 9.6 (P = 0.008)

b System specific involvement in NCPRS (before and after galactose supplementation)

System specific involvement improved from 5.1 ± 2.7 to 3.6 ± 2.6 (P = 0.042)

c Current clinical assessment in NCPRS (before and after galactose supplementation)

Current clinical assessment improved from 12.1 ± 3.8 to 10.2 ± 3.7 (P = 0.007)